IP Library Granted Patent US 9,127,276
Granted Patent B2
US 9,127,276 · App. 14/267,842 · Granted Sep 8, 2015

Conjugated antisense compounds and their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,127,276
App. No.
14/267,842
Granted
Sep 8, 2015
Kind
B2
Abstract

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.

Claims (12)

1. A compound having the formula (XXVI):

wherein:

T 2 is a group comprising a nucleoside, a nucleotide, a monomeric subunit, a reactive ester, a linker, a cleavable moiety or an oligomeric compound.

2. The compound of claim 1 , wherein the linker comprises an amine, an amide, an ester, an ether, a pyrrolidine, PEG, a polyamide, or a disulfide bond.

3. The compound of claim 1 , wherein the linker does not comprise a pyrrolidine.

4. The compound of claim 1 , wherein the linker has the formula:

5. The compound of claim 1 , wherein T 2 has the formula:

wherein:

CM is a cleavable moiety and T 3 is a nucleoside, a nucleotide, a monomeric subunit, or an oligomeric compound.

6. The compound of claim 1 , wherein T 2 has the formula:

wherein:

T 3 is a nucleoside, a nucleotide, a monomeric subunit, or an oligomeric compound.

Assignments (2)
CHANGE OF NAME Recorded Jun 15, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 042821/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: PRAKASH, THAZHA P; SETH, PUNIT P.; SWAYZE, ERIC E.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 032934/0511 →